Anti-inflammatory properties of fermented soy milk with Lactococcus lactis subsp lactis S-SU2 in murine macrophage RAW264.7 cells and DSS-induced IBD model mice

作者：Kawahara Miho; Nemoto Maki; Nakata Toru; Kondo Saya; Takahashi Hajime; Kimura Bon; Kuda Takashi^*

来源：International Immunopharmacology, 2015, 26(2): 295-303.

DOI：10.1016/j.intimp.2015.04.004

• Anti-inflammation
• Lactococcus lactis subsp lactis
• murine macrophage RAW264.7
• Inflammation bowl disease
• Dextran sodium sulfate
• Mice

Six lactic acid bacteria strains (four Lactobacillus plantarum strains and one each of Lactococcus lactis subsp. lactis and Pediococcus pentosaceus) have been isolated and shown to possess anti-oxidant activity. In this study, we determined their acid, bile, salt resistance, and adhesion activity on human enterocyte-like HT-29-Luc and Caco-2 cells. An isolate Lc. lactis S-SU2 showed highest bile resistance and adhesion activity compared to type strains. S-SU2 could ferment both 10% skimmed milk and soy milk while the type strain could not ferment soy milk. Soy milk fermented with S-SU2 showed an increased nitric oxide (NO) secretion in the mouse macrophage RAW264.7 cells without bacterial lipopolysaccharide (LPS). Furthermore, the inhibitory effects of the fermented soy milk on Escherichia coil 0111 LPS-induced NO secretion were higher than those of fresh soy milk. Inflammatory bowel disease (IBD) was induced in mice fed either 5% (w/v) dextran sodium sulfate (DSS) in drinking water or 50% soy milk in drinking water. Shortening of colon length, breaking of epithelial cells, lowering liver and thymus weights, and enlargement of spleen are some of the characteristics observed in the IBD, which were prevented by the use of soy milk fermented with Lc. lactis S-SU2.

• 出版日期2015-6